Abstract
Biomedical Machine Learning (ML) is increasingly evaluated through Independent and Identically Distributed (IID) benchmarks, even when deployment involves irregular observation, missingness, distribution shift, and high failure costs. This position paper argues for a stability-oriented reporting standard for safety-relevant biomedical ML. The central requirement is not a specific model class or optimizer, but auditable evidence: performance should be reported under clinically plausible perturbations such as thinning, timestamp jitter, bursty missingness, channel dropout, and Signal-to-Noise Ratio (SNR) shift. When authors invoke training-stability diagnostics, those diagnostics should be hazard-linked: their assumptions, operational meaning, and relationship to stress-test degradation should be stated explicitly. We use controlled mechanism probes to illustrate two hazards that IID scores can hide: observation-process dependence under irregular sampling, and perturbation sensitivity associated with high-curvature training regimes such as Edge of Stability (EoS). We do not propose Neural ODEs, continuous-time models, Sharpness-Aware Minimization (SAM), or EoS metrics as default prescriptions. Instead, we propose a minimum reporting standard that makes robustness claims testable and supports escalation to more complex modelling or optimization only when stress tests justify the cost.
Competing Interest Statement
The authors have declared no competing interest.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used ONLY openly available human data that were originally located at the following repositories: CHB-MIT Scalp EEG Database: Available via PhysioNet at https://physionet.org/content/chbmit/1.0.0/. PathMNIST: A publicly available dataset from the MedMNIST v2 benchmark. CIFAR-10: An open-access image classification dataset. All datasets are public resources used in accordance with their respective open-access licenses (Open Data Commons Attribution License v1.0, CC BY 4.0, and MIT).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
omid.kavehei{at}sydney.edu.au
isabelle.aguilar{at}sydney.edu.au
luis.herbozocontreras{at}sydney.edu.au
zhaojing.huang{at}sydney.edu.au
Data Availability
All datasets analysed in the present study are publicly available open-access resources. The CHB-MIT Scalp EEG Database is available via PhysioNet at https://physionet.org/content/chbmit/1.0.0/. The PathMNIST and CIFAR-10 datasets are also openly accessible via their respective original repositories. No new primary datasets were generated for this study.





